Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.75 Billion CNY | 28.19% |
| 2022 | 2.14 Billion CNY | 18.2% |
| 2021 | 1.81 Billion CNY | 6.91% |
| 2020 | 1.69 Billion CNY | 25.99% |
| 2019 | 1.34 Billion CNY | 20.25% |
| 2018 | 1.11 Billion CNY | 24.61% |
| 2017 | 897.29 Million CNY | 23.43% |
| 2016 | 726.96 Million CNY | 31.32% |
| 2015 | 553.59 Million CNY | 33.55% |
| 2014 | 414.52 Million CNY | 51.72% |
| 2013 | 273.21 Million CNY | 57.59% |
| 2012 | 173.37 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 864.59 Million CNY | 5.77% |
| 2024 Q1 | 749.99 Million CNY | 3.06% |
| 2024 Q2 | 817.41 Million CNY | 8.99% |
| 2023 Q1 | 601.55 Million CNY | 10.79% |
| 2023 FY | 2.74 Billion CNY | 28.19% |
| 2023 Q4 | 727.71 Million CNY | -6.17% |
| 2023 Q3 | 775.56 Million CNY | 6.49% |
| 2023 Q2 | 728.32 Million CNY | 21.07% |
| 2022 FY | 2.14 Billion CNY | 18.2% |
| 2022 Q1 | 535.66 Million CNY | 11.47% |
| 2022 Q4 | 542.96 Million CNY | -12.38% |
| 2022 Q3 | 619.68 Million CNY | 40.06% |
| 2022 Q2 | 442.43 Million CNY | -17.41% |
| 2021 FY | 1.81 Billion CNY | 6.91% |
| 2021 Q4 | 480.54 Million CNY | 3.41% |
| 2021 Q3 | 464.68 Million CNY | -4.77% |
| 2021 Q1 | 377.92 Million CNY | -19.28% |
| 2021 Q2 | 487.94 Million CNY | 29.11% |
| 2020 Q1 | 203.44 Million CNY | -48.48% |
| 2020 Q4 | 468.18 Million CNY | 2.59% |
| 2020 FY | 1.69 Billion CNY | 25.99% |
| 2020 Q2 | 566.07 Million CNY | 178.25% |
| 2020 Q3 | 456.38 Million CNY | -19.38% |
| 2019 Q3 | 362.24 Million CNY | 8.19% |
| 2019 Q2 | 334.81 Million CNY | 32.55% |
| 2019 Q1 | 252.6 Million CNY | 0.0% |
| 2019 Q4 | 394.91 Million CNY | 9.02% |
| 2019 FY | 1.34 Billion CNY | 20.25% |
| 2018 FY | 1.11 Billion CNY | 24.61% |
| 2017 FY | 897.29 Million CNY | 23.43% |
| 2016 Q1 | 156.71 Million CNY | -0.5% |
| 2016 FY | 726.96 Million CNY | 31.32% |
| 2016 Q4 | 206.76 Million CNY | 0.0% |
| 2016 Q3 | 206.76 Million CNY | 31.94% |
| 2016 Q2 | 156.71 Million CNY | 0.0% |
| 2015 Q3 | 157.49 Million CNY | 32.02% |
| 2015 Q2 | 119.29 Million CNY | 0.0% |
| 2015 Q1 | 119.29 Million CNY | 3.71% |
| 2015 Q4 | 157.49 Million CNY | 0.0% |
| 2015 FY | 553.59 Million CNY | 33.55% |
| 2014 FY | 414.52 Million CNY | 51.72% |
| 2014 Q2 | 92.23 Million CNY | 0.0% |
| 2014 Q1 | 92.23 Million CNY | 12.89% |
| 2014 Q4 | 115.03 Million CNY | 0.0% |
| 2014 Q3 | 115.03 Million CNY | 24.72% |
| 2013 Q2 | 54.9 Million CNY | 0.0% |
| 2013 Q4 | 81.69 Million CNY | 0.0% |
| 2013 FY | 273.21 Million CNY | 57.59% |
| 2013 Q3 | 81.69 Million CNY | 48.78% |
| 2013 Q1 | 54.9 Million CNY | 0.0% |
| 2012 FY | 173.37 Million CNY | 0.0% |